Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	entity_9	entity_10	json	split
These results show that, physiologically, high levels of nuclear of p50, p52 and RelB are restricted to accessory cells of the immune system, which include FDC in GC, and DC and macrophages in the T cell zone, that specialized scavenger macrophages from GC do not have detectable levels of p52 and RelB, whereas macrophages from the T cell area, known to present the antigen to T cells, do have both nuclear p52 and RelB, and that in the T cell zone, p52 and RelB are located in nuclei of both CD1a +, CD68 + or both, cells APC, whereas p50 is restricted to CD1a - and CD68 - APC.	p50,68,71,Gene/Protein	p52,73,76,Gene/Protein	RelB,81,85,Gene/Protein	p52,290,293,Gene/Protein	RelB,298,302,Gene/Protein	p52,408,411,Gene/Protein	RelB,416,420,Gene/Protein	p52,451,454,Gene/Protein	RelB,459,463,Gene/Protein	p50,537,540,Gene/Protein	"[{""token"": ""p50"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 290, ""end_span"": 293, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 298, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 408, ""end_span"": 411, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 416, ""end_span"": 420, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 451, ""end_span"": 454, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 459, ""end_span"": 463, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 537, ""end_span"": 540, ""type"": ""Gene/Protein""}]"	train
B - cell - specific transcription of immunoglobulin genes is mediated by the interaction of a POU domain containing transcription factor Oct - 1 or Oct - 2, with the B - cell - specific coactivator OCA - B ( Bob - 1, OBF - 1) and a prototype octamer element.	immunoglobulin genes,37,57,Gene/Protein	POU domain,94,104,Gene/Protein	transcription factor,116,136,Gene/Protein	Oct - 1,137,144,Gene/Protein	Oct - 2,148,155,Gene/Protein	B - cell - specific coactivator,166,197,Gene/Protein	OCA - B,198,205,Gene/Protein	Bob - 1,208,215,Gene/Protein	OBF - 1,217,224,Gene/Protein	prototype octamer element,232,257,Gene/Protein	"[{""token"": ""immunoglobulin genes"", ""start_span"": 37, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""POU domain"", ""start_span"": 94, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 116, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific coactivator"", ""start_span"": 166, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""OCA - B"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""Bob - 1"", ""start_span"": 208, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""OBF - 1"", ""start_span"": 217, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""prototype octamer element"", ""start_span"": 232, ""end_span"": 257, ""type"": ""Gene/Protein""}]"	train
We questioned whether or not IL - 10 and IL - 4 affected the expression of transcription factors that are known to be involved in the control of the IL - 6 transcription rate, namely activator protein - 1 ( AP - 1), nuclear factor IL - 6 ( NF - IL6), and nuclear factor kappa B ( NF - kappaB).	IL - 10,29,36,Gene/Protein	IL - 4,41,47,Gene/Protein	transcription factors,75,96,Gene/Protein	IL - 6,149,155,Gene/Protein	AP - 1,207,213,Gene/Protein	nuclear factor,216,230,Gene/Protein	IL - 6,231,237,Gene/Protein	NF - IL6,240,248,Gene/Protein	nuclear factor kappa B,255,277,Gene/Protein	NF - kappaB,280,291,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 75, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 207, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor"", ""start_span"": 216, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 231, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6"", ""start_span"": 240, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B"", ""start_span"": 255, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 280, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	train
Transient transfection of endothelial cells with ICAM - 1 promoter luciferase reporter gene ( ICAM - 1LUC) constructs indicated that deletion of upstream NF - kappa B site ( - 533 bases from translation start site) had no effect on thrombin responsiveness, whereas mutation / deletion of downstream NF - kappa B site ( - 223 bases from the translation start site) prevented the activation of ICAM - 1 promoter, indicating that the downstream NF - kappa B site is critical for thrombin inducibility.	NF - kappa B site,154,171,Gene/Protein	- 533 bases,174,185,Gene/Protein	translation start site,191,213,Gene/Protein	thrombin,232,240,Gene/Protein	NF - kappa B site,299,316,Gene/Protein	- 223 bases,319,330,Gene/Protein	translation start site,340,362,Gene/Protein	ICAM - 1 promoter,392,409,Gene/Protein	NF - kappa B site,442,459,Gene/Protein	thrombin,476,484,Gene/Protein	"[{""token"": ""NF - kappa B site"", ""start_span"": 154, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""- 533 bases"", ""start_span"": 174, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""translation start site"", ""start_span"": 191, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""thrombin"", ""start_span"": 232, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 299, ""end_span"": 316, ""type"": ""Gene/Protein""}, {""token"": ""- 223 bases"", ""start_span"": 319, ""end_span"": 330, ""type"": ""Gene/Protein""}, {""token"": ""translation start site"", ""start_span"": 340, ""end_span"": 362, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 promoter"", ""start_span"": 392, ""end_span"": 409, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 442, ""end_span"": 459, ""type"": ""Gene/Protein""}, {""token"": ""thrombin"", ""start_span"": 476, ""end_span"": 484, ""type"": ""Gene/Protein""}]"	train
CD40 ligation on MM by CD40L - transfected murine L - cells or by a soluble CD40L fusion protein up - regulated their expression of intercellular adhesion molecule - 1 and MHC class I and class II molecules and their secretion of IL - 6, IL - 8, tumor necrosis factor - a, and granulocyte macrophage colony - stimulating factor and also induced a rapid activation of the transcription factor nuclear factor kappaB.	CD40,0,4,Gene/Protein	CD40L fusion protein,76,96,Gene/Protein	intercellular adhesion molecule - 1,132,167,Gene/Protein	MHC class I and class II molecules,172,206,Gene/Protein	IL - 6,230,236,Gene/Protein	IL - 8,238,244,Gene/Protein	tumor necrosis factor - a,246,271,Gene/Protein	granulocyte macrophage colony - stimulating factor,277,327,Gene/Protein	transcription factor,371,391,Gene/Protein	nuclear factor kappaB,392,413,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""CD40L fusion protein"", ""start_span"": 76, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 132, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""MHC class I and class II molecules"", ""start_span"": 172, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 230, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - a"", ""start_span"": 246, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte macrophage colony - stimulating factor"", ""start_span"": 277, ""end_span"": 327, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 371, ""end_span"": 391, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappaB"", ""start_span"": 392, ""end_span"": 413, ""type"": ""Gene/Protein""}]"	train
We reasoned that selective IFN responsiveness of the first STAT family member ( Stat1) and Stat1 - dependent immune - response genes such as intercellular adhesion molecule - 1 ( ICAM - 1), IFN regulatory factor - 1 ( IRF - 1), and Stat1 itself in airway epithelial cells provides a basis for detecting cytokine signaling abnormalities in inflammatory airway disease.	IFN,27,30,Gene/Protein	STAT family member,59,77,Gene/Protein	Stat1,80,85,Gene/Protein	Stat1 - dependent immune - response genes,91,132,Gene/Protein	intercellular adhesion molecule - 1,141,176,Gene/Protein	ICAM - 1,179,187,Gene/Protein	IFN regulatory factor - 1,190,215,Gene/Protein	IRF - 1,218,225,Gene/Protein	Stat1,232,237,Gene/Protein	cytokine,303,311,Gene/Protein	"[{""token"": ""IFN"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""STAT family member"", ""start_span"": 59, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Stat1 - dependent immune - response genes"", ""start_span"": 91, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 141, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 179, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""IFN regulatory factor - 1"", ""start_span"": 190, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 303, ""end_span"": 311, ""type"": ""Gene/Protein""}]"	train
First, we showed that viral binding induced a number of immunoregulatory genes ( IL - 1beta, A20, NF - kappaB - p105 / p50, and IkappaBalpha) in unactivated monocytes and that neutralizing Abs to the major HCMV glycoproteins, gB ( UL55) and gH ( UL75), inhibited the induction of these genes.	IL - 1beta,81,91,Gene/Protein	A20,93,96,Gene/Protein	NF - kappaB - p105 / p50,98,122,Gene/Protein	IkappaBalpha,128,140,Gene/Protein	neutralizing Abs,176,192,Gene/Protein	HCMV glycoproteins,206,224,Gene/Protein	gB,226,228,Gene/Protein	UL55,231,235,Gene/Protein	gH,241,243,Gene/Protein	UL75,246,250,Gene/Protein	"[{""token"": ""IL - 1beta"", ""start_span"": 81, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""A20"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB - p105 / p50"", ""start_span"": 98, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""neutralizing Abs"", ""start_span"": 176, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""HCMV glycoproteins"", ""start_span"": 206, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""gB"", ""start_span"": 226, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""UL55"", ""start_span"": 231, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""gH"", ""start_span"": 241, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""UL75"", ""start_span"": 246, ""end_span"": 250, ""type"": ""Gene/Protein""}]"	train
So far, we have identified five potential targets for Oct2: the membrane glycoprotein CD36, the cysteine - rich secreted protein 3 ( CRISP - 3), a mouse homolog of the human monocyte / neutrophil elastase inhibitor ( mEI) and two unknown cDNA sequences Nov1 and Nov2.	Oct2,54,58,Gene/Protein	membrane glycoprotein,64,85,Gene/Protein	CD36,86,90,Gene/Protein	cysteine - rich secreted protein 3,96,130,Gene/Protein	CRISP - 3,133,142,Gene/Protein	human monocyte / neutrophil elastase inhibitor,168,214,Gene/Protein	mEI,217,220,Gene/Protein	cDNA sequences,238,252,Gene/Protein	Nov1,253,257,Gene/Protein	Nov2,262,266,Gene/Protein	"[{""token"": ""Oct2"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""membrane glycoprotein"", ""start_span"": 64, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CD36"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""cysteine - rich secreted protein 3"", ""start_span"": 96, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""CRISP - 3"", ""start_span"": 133, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""human monocyte / neutrophil elastase inhibitor"", ""start_span"": 168, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""mEI"", ""start_span"": 217, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""cDNA sequences"", ""start_span"": 238, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""Nov1"", ""start_span"": 253, ""end_span"": 257, ""type"": ""Gene/Protein""}, {""token"": ""Nov2"", ""start_span"": 262, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
Transfection studies of LTR reporter constructs indicated that mutation of the DSE sites abrogated the LTR - mediated synergy induced by Ctx and TNFalpha, whereas the synergy induced by Ctx and IL - 1beta was unaffected, suggesting TNFalpha and IL - 1beta cooperate differently with the cAMP / PKA activation pathway to induce HIV - 1 expression in U1 cells.	LTR reporter constructs,24,47,Gene/Protein	DSE sites,79,88,Gene/Protein	LTR,103,106,Gene/Protein	Ctx,137,140,Gene/Protein	TNFalpha,145,153,Gene/Protein	Ctx,186,189,Gene/Protein	IL - 1beta,194,204,Gene/Protein	TNFalpha,232,240,Gene/Protein	IL - 1beta,245,255,Gene/Protein	/ PKA,292,297,Gene/Protein	"[{""token"": ""LTR reporter constructs"", ""start_span"": 24, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""DSE sites"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""Ctx"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""Ctx"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 232, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 245, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""/ PKA"", ""start_span"": 292, ""end_span"": 297, ""type"": ""Gene/Protein""}]"	train
Although NAC reduced nuclear factor - kappa B ( NF - kappa B) activation in EC as measured by gel - shift assays using an oligonucleotide probe corresponding to the consensus NF - kappa B binding sites of the VCAM - 1 gene ( VCAM - NF - kappa B), the antioxidant had no appreciable effect when an oligomer corresponding to the consensus NF - kappa B binding site of the E - selectin gene ( E - selectin - NF - kappa B) was used.	nuclear factor - kappa B,21,45,Gene/Protein	NF - kappa B,48,60,Gene/Protein	oligonucleotide probe,122,143,Gene/Protein	NF - kappa B binding sites,175,201,Gene/Protein	VCAM - 1 gene,209,222,Gene/Protein	VCAM - NF - kappa B,225,244,Gene/Protein	consensus NF - kappa B binding site,327,362,Gene/Protein	E - selectin gene,370,387,Gene/Protein	E - selectin,390,402,Gene/Protein	- NF - kappa B,403,417,Gene/Protein	"[{""token"": ""nuclear factor - kappa B"", ""start_span"": 21, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 48, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""oligonucleotide probe"", ""start_span"": 122, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B binding sites"", ""start_span"": 175, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1 gene"", ""start_span"": 209, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - NF - kappa B"", ""start_span"": 225, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""consensus NF - kappa B binding site"", ""start_span"": 327, ""end_span"": 362, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin gene"", ""start_span"": 370, ""end_span"": 387, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 390, ""end_span"": 402, ""type"": ""Gene/Protein""}, {""token"": ""- NF - kappa B"", ""start_span"": 403, ""end_span"": 417, ""type"": ""Gene/Protein""}]"	train
Synergistic transactivation of the LPS response element in Drosophila Schneider cells by coexpression of c - Fos, c - Jun, c - Rel, and p65 or c - Jun and p65 required the transactivation domains of c - Jun and p65.	LPS response element,35,55,Gene/Protein	c - Fos,105,112,Gene/Protein	c - Jun,114,121,Gene/Protein	c - Rel,123,130,Gene/Protein	p65,136,139,Gene/Protein	c - Jun,143,150,Gene/Protein	p65,155,158,Gene/Protein	transactivation domains,172,195,Gene/Protein	c - Jun,199,206,Gene/Protein	p65,211,214,Gene/Protein	"[{""token"": ""LPS response element"", ""start_span"": 35, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""transactivation domains"", ""start_span"": 172, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 199, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
We found, however, that PI 3 - kinase profoundly influenced the transactivation capacity of ' nuclear factor of activated T cells ' ( NF - AT) elicited by the TCR: expression of an activated form of PI 3 - kinase inhibited TCR - mediated NF - AT responses, whereas expression of a dominant negative mutant of PI 3 - kinase potently enhanced TCR - controlled NF - AT induction.	PI 3 - kinase,24,37,Gene/Protein	nuclear factor of activated T cells,94,129,Gene/Protein	NF - AT,134,141,Gene/Protein	TCR,159,162,Gene/Protein	PI 3 - kinase,199,212,Gene/Protein	TCR,223,226,Gene/Protein	NF - AT,238,245,Gene/Protein	PI 3 - kinase,309,322,Gene/Protein	TCR,341,344,Gene/Protein	NF - AT,358,365,Gene/Protein	"[{""token"": ""PI 3 - kinase"", ""start_span"": 24, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 94, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 199, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 223, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 238, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 309, ""end_span"": 322, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 341, ""end_span"": 344, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 358, ""end_span"": 365, ""type"": ""Gene/Protein""}]"	train
A dominant - negative mutant of NF - kappaB p50 that binds DNA but fails to interact with Ets proteins inhibits the synergistic activation of the HIV - 1 and HIV - 2 enhancers by NF - kappaB ( p50 + p65) and Ets - 1, suggesting that physical interaction between Ets and NF - kappaB proteins is required for the transcriptional activity of the HIV - 1 and HIV - 2 enhancers.	NF - kappaB p50,32,47,Gene/Protein	Ets proteins,90,102,Gene/Protein	HIV - 1 and HIV - 2 enhancers,146,175,Gene/Protein	NF - kappaB,179,190,Gene/Protein	p50,193,196,Gene/Protein	p65,199,202,Gene/Protein	Ets - 1,208,215,Gene/Protein	Ets,262,265,Gene/Protein	NF - kappaB proteins,270,290,Gene/Protein	HIV - 1 and HIV - 2 enhancers,343,372,Gene/Protein	"[{""token"": ""NF - kappaB p50"", ""start_span"": 32, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Ets proteins"", ""start_span"": 90, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 and HIV - 2 enhancers"", ""start_span"": 146, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 179, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1"", ""start_span"": 208, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""Ets"", ""start_span"": 262, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB proteins"", ""start_span"": 270, ""end_span"": 290, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 and HIV - 2 enhancers"", ""start_span"": 343, ""end_span"": 372, ""type"": ""Gene/Protein""}]"	train
A point mutation of a potential phosphatidylinositol 3 - kinase ( PI3 - K) binding site ( Y731EAM to Y731EAC) in 70Z / 3 disrupted the association of PI3 - K with 70Z / 3, but did not reduce the induction of NFAT activity, suggesting that the interaction between Cbl and PI3 - K is not required in the 70Z / 3 - mediated induction of NFAT.	Y731EAM,90,97,Gene/Protein	Y731EAC,101,108,Gene/Protein	70Z / 3,113,120,Gene/Protein	PI3 - K,150,157,Gene/Protein	70Z / 3,163,170,Gene/Protein	NFAT,208,212,Gene/Protein	Cbl,263,266,Gene/Protein	PI3 - K,271,278,Gene/Protein	70Z / 3,302,309,Gene/Protein	NFAT,334,338,Gene/Protein	"[{""token"": ""Y731EAM"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""Y731EAC"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""70Z / 3"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""PI3 - K"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""70Z / 3"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 208, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""Cbl"", ""start_span"": 263, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""PI3 - K"", ""start_span"": 271, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""70Z / 3"", ""start_span"": 302, ""end_span"": 309, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 334, ""end_span"": 338, ""type"": ""Gene/Protein""}]"	train
While IL - 4 does not activate STAT5, it induces expression of STAT5 - regulated genes in CTLL - 2, i. e. beta - casein, a cytokine - inducible SH2 - containing protein ( CIS), and oncostatin M ( OSM), suggesting that STAT6 activated by IL - 4 substitutes for the function of STAT5 in T cells.	IL - 4,6,12,Gene/Protein	STAT5,31,36,Gene/Protein	STAT5 - regulated genes,63,86,Gene/Protein	beta - casein,106,119,Gene/Protein	cytokine - inducible SH2 - containing protein,123,168,Gene/Protein	CIS,171,174,Gene/Protein	oncostatin M,181,193,Gene/Protein	OSM,196,199,Gene/Protein	IL - 4,237,243,Gene/Protein	STAT5,276,281,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""STAT5 - regulated genes"", ""start_span"": 63, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""beta - casein"", ""start_span"": 106, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""cytokine - inducible SH2 - containing protein"", ""start_span"": 123, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""CIS"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""oncostatin M"", ""start_span"": 181, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""OSM"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 237, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 276, ""end_span"": 281, ""type"": ""Gene/Protein""}]"	train
Our studies now demonstrate that HTLV - 1 Tax activates the recently identified cellular kinases IkappaB kinase alpha ( IKKalpha) and IKKbeta, which normally phosphorylate IkappaB alpha on both of its N - terminal regulatory serines in response to tumor necrosis factor alpha ( TNF - alpha) and interleukin - 1 ( IL - 1) stimulation.	Tax,42,45,Gene/Protein	cellular kinases,80,96,Gene/Protein	IkappaB kinase alpha,97,117,Gene/Protein	IKKalpha,120,128,Gene/Protein	IKKbeta,134,141,Gene/Protein	IkappaB alpha,172,185,Gene/Protein	tumor necrosis factor alpha,248,275,Gene/Protein	TNF - alpha,278,289,Gene/Protein	interleukin - 1,295,310,Gene/Protein	IL - 1,313,319,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""cellular kinases"", ""start_span"": 80, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB kinase alpha"", ""start_span"": 97, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB alpha"", ""start_span"": 172, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 248, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 278, ""end_span"": 289, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1"", ""start_span"": 295, ""end_span"": 310, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 313, ""end_span"": 319, ""type"": ""Gene/Protein""}]"	train
We have previously reported that the T lymphocytes of a child with severe combined immunodeficiency are defective in the transcription of several lymphokine genes that include IL2, IL3, IL4, and IL5, which encode interleukins 2, 3, 4, and 5 ( IL - 2, - 3, - 4, and - 5).	lymphokine genes,146,162,Gene/Protein	IL2,176,179,Gene/Protein	IL3,181,184,Gene/Protein	IL4,186,189,Gene/Protein	IL5,195,198,Gene/Protein	interleukins,213,225,Gene/Protein	IL - 2,243,249,Gene/Protein	- 3,251,254,Gene/Protein	- 4,256,259,Gene/Protein	- 5,265,268,Gene/Protein	"[{""token"": ""lymphokine genes"", ""start_span"": 146, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""IL2"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""IL3"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""IL4"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""IL5"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""interleukins"", ""start_span"": 213, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 243, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""- 3"", ""start_span"": 251, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""- 4"", ""start_span"": 256, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""- 5"", ""start_span"": 265, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
The Rel / NF - kappa B family of transcription factors is composed of two distinct subgroups, proteins that undergo proteolytic processing and contain SWI6 / ankyrin repeats in their carboxyl termini ( p105, p98), and those without such repeats that do not require processing ( p65, c - Rel, RelB, and Dorsal).	Rel / NF - kappa B family,4,29,Gene/Protein	transcription factors,33,54,Gene/Protein	SWI6 / ankyrin repeats,151,173,Gene/Protein	carboxyl termini,183,199,Gene/Protein	p105,202,206,Gene/Protein	p98,208,211,Gene/Protein	p65,278,281,Gene/Protein	c - Rel,283,290,Gene/Protein	RelB,292,296,Gene/Protein	Dorsal,302,308,Gene/Protein	"[{""token"": ""Rel / NF - kappa B family"", ""start_span"": 4, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 33, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""SWI6 / ankyrin repeats"", ""start_span"": 151, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""carboxyl termini"", ""start_span"": 183, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""p98"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 278, ""end_span"": 281, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 283, ""end_span"": 290, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 292, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""Dorsal"", ""start_span"": 302, ""end_span"": 308, ""type"": ""Gene/Protein""}]"	train
In this study, we demonstrate reconstitution of a cell - free processing system and demonstrate directly that: ( a) the ubiquitin - proteasome system is involved in processing of the intact p105 precursor, ( b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, ( c) the recently discovered novel species of the ubiquitin - carrier protein, E2 - F1, that is involved in the conjugation and degradation of p53, is also required for the limited processing of the p105 precursor, and ( d) a novel, approximately 320 - kDa species of ubiquitin - protein ligase, is involved in the process.	ubiquitin,120,129,Gene/Protein	- proteasome,130,142,Gene/Protein	p105,190,194,Gene/Protein	ubiquitin,226,235,Gene/Protein	ubiquitin - carrier protein,356,383,Gene/Protein	E2 - F1,385,392,Gene/Protein	p53,449,452,Gene/Protein	p105 precursor,505,519,Gene/Protein	320 - kDa species,553,570,Gene/Protein	ubiquitin - protein ligase,574,600,Gene/Protein	"[{""token"": ""ubiquitin"", ""start_span"": 120, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""- proteasome"", ""start_span"": 130, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitin"", ""start_span"": 226, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitin - carrier protein"", ""start_span"": 356, ""end_span"": 383, ""type"": ""Gene/Protein""}, {""token"": ""E2 - F1"", ""start_span"": 385, ""end_span"": 392, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 449, ""end_span"": 452, ""type"": ""Gene/Protein""}, {""token"": ""p105 precursor"", ""start_span"": 505, ""end_span"": 519, ""type"": ""Gene/Protein""}, {""token"": ""320 - kDa species"", ""start_span"": 553, ""end_span"": 570, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitin - protein ligase"", ""start_span"": 574, ""end_span"": 600, ""type"": ""Gene/Protein""}]"	train
In THP - 1 cells, Fc gamma R cross - linking induced NF - kappa B, which is known to bind to the regulatory region of the long terminal repeat ( LTR) of HIV - 1 and to activate HIV - 1 transcription. Anti - TNF - alpha antibody but not anti - IL - 1 beta antibody strongly inhibited both the induction of HIV - 1 - LTR - driven transcription and the induction of NF - kappa B by Fc gamma R cross - linking.	Fc gamma R,18,28,Gene/Protein	NF - kappa B,53,65,Gene/Protein	regulatory region,97,114,Gene/Protein	long terminal repeat,122,142,Gene/Protein	LTR,145,148,Gene/Protein	Anti - TNF - alpha antibody,200,227,Gene/Protein	anti - IL - 1 beta antibody,236,263,Gene/Protein	LTR,315,318,Gene/Protein	NF - kappa B,363,375,Gene/Protein	Fc gamma R,379,389,Gene/Protein	"[{""token"": ""Fc gamma R"", ""start_span"": 18, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""regulatory region"", ""start_span"": 97, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeat"", ""start_span"": 122, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""Anti - TNF - alpha antibody"", ""start_span"": 200, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""anti - IL - 1 beta antibody"", ""start_span"": 236, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 315, ""end_span"": 318, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 363, ""end_span"": 375, ""type"": ""Gene/Protein""}, {""token"": ""Fc gamma R"", ""start_span"": 379, ""end_span"": 389, ""type"": ""Gene/Protein""}]"	train
Using fluorescence in situ hybridization ( FISH), we show here that the genes encoding the TATA - box binding protein ( TBP), TFIIB, TFIIE alpha, TFIIE beta, RAP30, RAP74 and the 62 kDa subunit, of TFIIH are located at the human chromosomal bands 6q26 - 27, 1p21 - 22, 3q21 - 24, 8p12, 13q14, 19p13. 3 and 11p14 - 15. 1, respectively.	genes,72,77,Gene/Protein	TATA - box binding protein,91,117,Gene/Protein	TBP,120,123,Gene/Protein	TFIIB,126,131,Gene/Protein	TFIIE alpha,133,144,Gene/Protein	TFIIE beta,146,156,Gene/Protein	RAP30,158,163,Gene/Protein	RAP74,165,170,Gene/Protein	62 kDa subunit,179,193,Gene/Protein	TFIIH,198,203,Gene/Protein	"[{""token"": ""genes"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TATA - box binding protein"", ""start_span"": 91, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""TBP"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""TFIIB"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""TFIIE alpha"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""TFIIE beta"", ""start_span"": 146, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""RAP30"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""RAP74"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""62 kDa subunit"", ""start_span"": 179, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""TFIIH"", ""start_span"": 198, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	valid
To determine the contribution of the cytoplasmic domain of the IL - 7 receptor alpha chain ( IL - 7R alpha) to activation of STAT proteins, transfectants of the murine pro - B cell line BAF3 were made that express chimeric receptors consisting of the extracellular domain of human granulocyte colony - stimulating factor receptor ( G - CSF - R) and the transmembrane and intracellular domains of human IL - 7R alpha.	cytoplasmic domain,37,55,Gene/Protein	IL - 7 receptor alpha chain,63,90,Gene/Protein	IL - 7R alpha,93,106,Gene/Protein	STAT proteins,125,138,Gene/Protein	chimeric receptors,214,232,Gene/Protein	extracellular domain,251,271,Gene/Protein	human granulocyte colony - stimulating factor receptor,275,329,Gene/Protein	G - CSF - R,332,343,Gene/Protein	transmembrane and intracellular domains,353,392,Gene/Protein	human IL - 7R alpha,396,415,Gene/Protein	"[{""token"": ""cytoplasmic domain"", ""start_span"": 37, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7 receptor alpha chain"", ""start_span"": 63, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7R alpha"", ""start_span"": 93, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""STAT proteins"", ""start_span"": 125, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""chimeric receptors"", ""start_span"": 214, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""extracellular domain"", ""start_span"": 251, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""human granulocyte colony - stimulating factor receptor"", ""start_span"": 275, ""end_span"": 329, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF - R"", ""start_span"": 332, ""end_span"": 343, ""type"": ""Gene/Protein""}, {""token"": ""transmembrane and intracellular domains"", ""start_span"": 353, ""end_span"": 392, ""type"": ""Gene/Protein""}, {""token"": ""human IL - 7R alpha"", ""start_span"": 396, ""end_span"": 415, ""type"": ""Gene/Protein""}]"	valid
This effect was specifically due to Tat, since Jurkat and U937 cells cotransfected either with tat cDNA in antisense orientation ( tat / AS), tat carrying a mutation in the aminoacid cys22 - gly22 ( tat 22 / S) or with the backbone vector alone ( pRPneo - SL3) did not show any significant difference in c - fos promoter activity as compared to cells transfected with FC3 plasmid alone.	Tat,36,39,Gene/Protein	tat cDNA,95,103,Gene/Protein	tat / AS,131,139,Gene/Protein	tat,142,145,Gene/Protein	aminoacid cys22 - gly22,173,196,Gene/Protein	tat 22 / S,199,209,Gene/Protein	backbone vector alone,223,244,Gene/Protein	pRPneo - SL3,247,259,Gene/Protein	c - fos promoter,304,320,Gene/Protein	FC3 plasmid,368,379,Gene/Protein	"[{""token"": ""Tat"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""tat cDNA"", ""start_span"": 95, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""tat / AS"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""tat"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""aminoacid cys22 - gly22"", ""start_span"": 173, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""tat 22 / S"", ""start_span"": 199, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""backbone vector alone"", ""start_span"": 223, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""pRPneo - SL3"", ""start_span"": 247, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""c - fos promoter"", ""start_span"": 304, ""end_span"": 320, ""type"": ""Gene/Protein""}, {""token"": ""FC3 plasmid"", ""start_span"": 368, ""end_span"": 379, ""type"": ""Gene/Protein""}]"	valid
V3 - BH10 neither blocked radiolabeled IL - 2 binding to IL - 2 receptors nor affected tyrosyl phosphorylation of several cellular proteins ( p120, p98, p96, p54, and p38), which is immediately induced by IL - 2 stimulation.	V3 - BH10,0,9,Gene/Protein	IL - 2,39,45,Gene/Protein	IL - 2 receptors,57,73,Gene/Protein	cellular proteins,122,139,Gene/Protein	p120,142,146,Gene/Protein	p98,148,151,Gene/Protein	p96,153,156,Gene/Protein	p54,158,161,Gene/Protein	p38,167,170,Gene/Protein	IL - 2,205,211,Gene/Protein	"[{""token"": ""V3 - BH10"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptors"", ""start_span"": 57, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""cellular proteins"", ""start_span"": 122, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""p120"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""p98"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""p96"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""p54"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""p38"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	valid
The eosinophilic characteristics of YJ cells were confirmed by histochemical staining with Fast - Green / Neutral - Red and by the expression of mRNAs for eosinophil - associated granule proteins, eosinophil cationic protein ( ECP), eosinophil - derived neurotoxin ( EDN), eosinophil peroxidase ( EPO), and major basic protein ( MBP), and for the Charcot - Leyden crystal ( CLC) protein.	mRNAs,145,150,Gene/Protein	eosinophil - associated granule proteins,155,195,Gene/Protein	eosinophil cationic protein,197,224,Gene/Protein	ECP,227,230,Gene/Protein	eosinophil - derived neurotoxin,233,264,Gene/Protein	EDN,267,270,Gene/Protein	eosinophil peroxidase,273,294,Gene/Protein	EPO,297,300,Gene/Protein	major basic protein,307,326,Gene/Protein	MBP,329,332,Gene/Protein	"[{""token"": ""mRNAs"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil - associated granule proteins"", ""start_span"": 155, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil cationic protein"", ""start_span"": 197, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""ECP"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil - derived neurotoxin"", ""start_span"": 233, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""EDN"", ""start_span"": 267, ""end_span"": 270, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil peroxidase"", ""start_span"": 273, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 297, ""end_span"": 300, ""type"": ""Gene/Protein""}, {""token"": ""major basic protein"", ""start_span"": 307, ""end_span"": 326, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 329, ""end_span"": 332, ""type"": ""Gene/Protein""}]"	valid
Nonetheless, a membrane - proximal region of human IL - 2R beta ( Asn240 - Leu335) was critical for JAK3 activation, and the amount of JAK3 present in activated IL - 2 receptor complexes increased with time, suggesting that stabilization of JAK3 binding to the receptor complex relies on both IL - 2R beta and IL - 2R gamma.	membrane - proximal region,15,41,Gene/Protein	IL - 2R beta,51,63,Gene/Protein	Asn240 - Leu335,66,81,Gene/Protein	JAK3,100,104,Gene/Protein	JAK3,135,139,Gene/Protein	IL - 2 receptor complexes,161,186,Gene/Protein	JAK3,241,245,Gene/Protein	receptor complex,261,277,Gene/Protein	IL - 2R beta,293,305,Gene/Protein	IL - 2R gamma,310,323,Gene/Protein	"[{""token"": ""membrane - proximal region"", ""start_span"": 15, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 51, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Asn240 - Leu335"", ""start_span"": 66, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor complexes"", ""start_span"": 161, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 241, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""receptor complex"", ""start_span"": 261, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 293, ""end_span"": 305, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R gamma"", ""start_span"": 310, ""end_span"": 323, ""type"": ""Gene/Protein""}]"	valid
Evolution of a case of chronic lymphocytic leukemia ( CLL) into blast crisis was found to be characterized by three unusual features ( 1) the phenotype of the emerging blast cells was that of pre - plasmacytoid cells as shown by plasma cell morphology and an immunological phenotype corresponding partially with CLL - or intermediate B - cells, partially with plasma cells ( terminal transferase -, common acute lymphocytic leukemia antigen -, Ia +, surface immunoglobulin heavy chains -, surface kappa light chains +, intracytoplasmic immunoglobulin A + and G +, BA - 1 +, polyclonal gammaglobulin production); ( 2) cytogenetic analysis of spontaneous metaphases revealed that in addition to the typical CLL abnormality, trisomy 12, in all of the cells, an additional translocation between chromosomes 14 and 17 was present in 40% with a presumptive breakpoint on chromosome 14 ( q12 - 3) never described before ( commonly q32) and ( 3) the progression of the disease was associated with a striking increase in the expression by the transformed cells of specific binding sites for estradiol ( E2) due to an actual increase in total cellular receptor proteins and not to a change in receptor affinity for E2.	terminal transferase,375,395,Gene/Protein	acute lymphocytic leukemia antigen,406,440,Gene/Protein	Ia +,444,448,Gene/Protein	surface immunoglobulin heavy chains,450,485,Gene/Protein	surface kappa light chains,489,515,Gene/Protein	intracytoplasmic immunoglobulin A + and G +,519,562,Gene/Protein	BA - 1 +,564,572,Gene/Protein	chromosomes 14 and 17,791,812,Gene/Protein	chromosome 14,865,878,Gene/Protein	cellular receptor proteins,1133,1159,Gene/Protein	"[{""token"": ""terminal transferase"", ""start_span"": 375, ""end_span"": 395, ""type"": ""Gene/Protein""}, {""token"": ""acute lymphocytic leukemia antigen"", ""start_span"": 406, ""end_span"": 440, ""type"": ""Gene/Protein""}, {""token"": ""Ia +"", ""start_span"": 444, ""end_span"": 448, ""type"": ""Gene/Protein""}, {""token"": ""surface immunoglobulin heavy chains"", ""start_span"": 450, ""end_span"": 485, ""type"": ""Gene/Protein""}, {""token"": ""surface kappa light chains"", ""start_span"": 489, ""end_span"": 515, ""type"": ""Gene/Protein""}, {""token"": ""intracytoplasmic immunoglobulin A + and G +"", ""start_span"": 519, ""end_span"": 562, ""type"": ""Gene/Protein""}, {""token"": ""BA - 1 +"", ""start_span"": 564, ""end_span"": 572, ""type"": ""Gene/Protein""}, {""token"": ""chromosomes 14 and 17"", ""start_span"": 791, ""end_span"": 812, ""type"": ""Gene/Protein""}, {""token"": ""chromosome 14"", ""start_span"": 865, ""end_span"": 878, ""type"": ""Gene/Protein""}, {""token"": ""cellular receptor proteins"", ""start_span"": 1133, ""end_span"": 1159, ""type"": ""Gene/Protein""}]"	test
These mutations prevent CD40 ligand ( CD40L) - mediated degradation of inhibitor of NF - kappaB alpha ( IkappaB - alpha) and account for the following observations: B cells from XHM - ED patients are unable to undergo immunoglobulin class - switch recombination and antigen - presenting cells ( APCs) are unable to synthesize the NF - kappaB - regulated cytokines interleukin 12 ( IL - 12) or tumor necrosis factor alpha ( TNF - alpha) when stimulated with CD40L.	CD40 ligand,24,35,Gene/Protein	CD40L,38,43,Gene/Protein	NF - kappaB alpha,84,101,Gene/Protein	IkappaB - alpha,104,119,Gene/Protein	NF - kappaB - regulated cytokines,330,363,Gene/Protein	interleukin 12,364,378,Gene/Protein	IL - 12,381,388,Gene/Protein	tumor necrosis factor alpha,393,420,Gene/Protein	TNF - alpha,423,434,Gene/Protein	CD40L,457,462,Gene/Protein	"[{""token"": ""CD40 ligand"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB alpha"", ""start_span"": 84, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 104, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB - regulated cytokines"", ""start_span"": 330, ""end_span"": 363, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 12"", ""start_span"": 364, ""end_span"": 378, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 381, ""end_span"": 388, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 393, ""end_span"": 420, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 423, ""end_span"": 434, ""type"": ""Gene/Protein""}, {""token"": ""CD40L"", ""start_span"": 457, ""end_span"": 462, ""type"": ""Gene/Protein""}]"	test
The objectives of this study were ( 1) to define the kinetics of NF kappa B activation by examining I kappa B alpha degradation and the nuclear translocation of p65 in response to A / R or redox imbalance ( induced by treatment of cells with diamide and buthionine sulfoximine) and ( 2) to determine whether the signal for I kappa B alpha degradation, nuclear translocation of p65, and E - selectin - mediated neutrophil adhesion is related to the activity of protein tyrosine kinase ( PTK), protein tyrosine phosphatase ( PTPase) and / or protein kinase C ( PKC).	NF kappa B,65,75,Gene/Protein	p65,161,164,Gene/Protein	p65,377,380,Gene/Protein	E - selectin,386,398,Gene/Protein	protein tyrosine kinase,460,483,Gene/Protein	PTK,486,489,Gene/Protein	protein tyrosine phosphatase,492,520,Gene/Protein	PTPase,523,529,Gene/Protein	protein kinase C,540,556,Gene/Protein	PKC,559,562,Gene/Protein	"[{""token"": ""NF kappa B"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 377, ""end_span"": 380, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 386, ""end_span"": 398, ""type"": ""Gene/Protein""}, {""token"": ""protein tyrosine kinase"", ""start_span"": 460, ""end_span"": 483, ""type"": ""Gene/Protein""}, {""token"": ""PTK"", ""start_span"": 486, ""end_span"": 489, ""type"": ""Gene/Protein""}, {""token"": ""protein tyrosine phosphatase"", ""start_span"": 492, ""end_span"": 520, ""type"": ""Gene/Protein""}, {""token"": ""PTPase"", ""start_span"": 523, ""end_span"": 529, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 540, ""end_span"": 556, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 559, ""end_span"": 562, ""type"": ""Gene/Protein""}]"	test
These results show that, physiologically, high levels of nuclear of p50, p52 and RelB are restricted to accessory cells of the immune system, which include FDC in GC, and DC and macrophages in the T cell zone, that specialized scavenger macrophages from GC do not have detectable levels of p52 and RelB, whereas macrophages from the T cell area, known to present the antigen to T cells, do have both nuclear p52 and RelB, and that in the T cell zone, p52 and RelB are located in nuclei of both CD1a +, CD68 + or both, cells APC, whereas p50 is restricted to CD1a - and CD68 - APC.	p50,68,71,Gene/Protein	p52,73,76,Gene/Protein	RelB,81,85,Gene/Protein	p52,290,293,Gene/Protein	RelB,298,302,Gene/Protein	p52,408,411,Gene/Protein	RelB,416,420,Gene/Protein	p52,451,454,Gene/Protein	RelB,459,463,Gene/Protein	p50,537,540,Gene/Protein	"[{""token"": ""p50"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 290, ""end_span"": 293, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 298, ""end_span"": 302, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 408, ""end_span"": 411, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 416, ""end_span"": 420, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 451, ""end_span"": 454, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 459, ""end_span"": 463, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 537, ""end_span"": 540, ""type"": ""Gene/Protein""}]"	train
B - cell - specific transcription of immunoglobulin genes is mediated by the interaction of a POU domain containing transcription factor Oct - 1 or Oct - 2, with the B - cell - specific coactivator OCA - B ( Bob - 1, OBF - 1) and a prototype octamer element.	immunoglobulin genes,37,57,Gene/Protein	POU domain,94,104,Gene/Protein	transcription factor,116,136,Gene/Protein	Oct - 1,137,144,Gene/Protein	Oct - 2,148,155,Gene/Protein	B - cell - specific coactivator,166,197,Gene/Protein	OCA - B,198,205,Gene/Protein	Bob - 1,208,215,Gene/Protein	OBF - 1,217,224,Gene/Protein	prototype octamer element,232,257,Gene/Protein	"[{""token"": ""immunoglobulin genes"", ""start_span"": 37, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""POU domain"", ""start_span"": 94, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 116, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 1"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""Oct - 2"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""B - cell - specific coactivator"", ""start_span"": 166, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""OCA - B"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""Bob - 1"", ""start_span"": 208, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""OBF - 1"", ""start_span"": 217, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""prototype octamer element"", ""start_span"": 232, ""end_span"": 257, ""type"": ""Gene/Protein""}]"	train
We questioned whether or not IL - 10 and IL - 4 affected the expression of transcription factors that are known to be involved in the control of the IL - 6 transcription rate, namely activator protein - 1 ( AP - 1), nuclear factor IL - 6 ( NF - IL6), and nuclear factor kappa B ( NF - kappaB).	IL - 10,29,36,Gene/Protein	IL - 4,41,47,Gene/Protein	transcription factors,75,96,Gene/Protein	IL - 6,149,155,Gene/Protein	AP - 1,207,213,Gene/Protein	nuclear factor,216,230,Gene/Protein	IL - 6,231,237,Gene/Protein	NF - IL6,240,248,Gene/Protein	nuclear factor kappa B,255,277,Gene/Protein	NF - kappaB,280,291,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 75, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""AP - 1"", ""start_span"": 207, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor"", ""start_span"": 216, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 231, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""NF - IL6"", ""start_span"": 240, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappa B"", ""start_span"": 255, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 280, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	train
Transient transfection of endothelial cells with ICAM - 1 promoter luciferase reporter gene ( ICAM - 1LUC) constructs indicated that deletion of upstream NF - kappa B site ( - 533 bases from translation start site) had no effect on thrombin responsiveness, whereas mutation / deletion of downstream NF - kappa B site ( - 223 bases from the translation start site) prevented the activation of ICAM - 1 promoter, indicating that the downstream NF - kappa B site is critical for thrombin inducibility.	NF - kappa B site,154,171,Gene/Protein	- 533 bases,174,185,Gene/Protein	translation start site,191,213,Gene/Protein	thrombin,232,240,Gene/Protein	NF - kappa B site,299,316,Gene/Protein	- 223 bases,319,330,Gene/Protein	translation start site,340,362,Gene/Protein	ICAM - 1 promoter,392,409,Gene/Protein	NF - kappa B site,442,459,Gene/Protein	thrombin,476,484,Gene/Protein	"[{""token"": ""NF - kappa B site"", ""start_span"": 154, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""- 533 bases"", ""start_span"": 174, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""translation start site"", ""start_span"": 191, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""thrombin"", ""start_span"": 232, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 299, ""end_span"": 316, ""type"": ""Gene/Protein""}, {""token"": ""- 223 bases"", ""start_span"": 319, ""end_span"": 330, ""type"": ""Gene/Protein""}, {""token"": ""translation start site"", ""start_span"": 340, ""end_span"": 362, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1 promoter"", ""start_span"": 392, ""end_span"": 409, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B site"", ""start_span"": 442, ""end_span"": 459, ""type"": ""Gene/Protein""}, {""token"": ""thrombin"", ""start_span"": 476, ""end_span"": 484, ""type"": ""Gene/Protein""}]"	train
CD40 ligation on MM by CD40L - transfected murine L - cells or by a soluble CD40L fusion protein up - regulated their expression of intercellular adhesion molecule - 1 and MHC class I and class II molecules and their secretion of IL - 6, IL - 8, tumor necrosis factor - a, and granulocyte macrophage colony - stimulating factor and also induced a rapid activation of the transcription factor nuclear factor kappaB.	CD40,0,4,Gene/Protein	CD40L fusion protein,76,96,Gene/Protein	intercellular adhesion molecule - 1,132,167,Gene/Protein	MHC class I and class II molecules,172,206,Gene/Protein	IL - 6,230,236,Gene/Protein	IL - 8,238,244,Gene/Protein	tumor necrosis factor - a,246,271,Gene/Protein	granulocyte macrophage colony - stimulating factor,277,327,Gene/Protein	transcription factor,371,391,Gene/Protein	nuclear factor kappaB,392,413,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""CD40L fusion protein"", ""start_span"": 76, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 132, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""MHC class I and class II molecules"", ""start_span"": 172, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 230, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - a"", ""start_span"": 246, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""granulocyte macrophage colony - stimulating factor"", ""start_span"": 277, ""end_span"": 327, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 371, ""end_span"": 391, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kappaB"", ""start_span"": 392, ""end_span"": 413, ""type"": ""Gene/Protein""}]"	train
We reasoned that selective IFN responsiveness of the first STAT family member ( Stat1) and Stat1 - dependent immune - response genes such as intercellular adhesion molecule - 1 ( ICAM - 1), IFN regulatory factor - 1 ( IRF - 1), and Stat1 itself in airway epithelial cells provides a basis for detecting cytokine signaling abnormalities in inflammatory airway disease.	IFN,27,30,Gene/Protein	STAT family member,59,77,Gene/Protein	Stat1,80,85,Gene/Protein	Stat1 - dependent immune - response genes,91,132,Gene/Protein	intercellular adhesion molecule - 1,141,176,Gene/Protein	ICAM - 1,179,187,Gene/Protein	IFN regulatory factor - 1,190,215,Gene/Protein	IRF - 1,218,225,Gene/Protein	Stat1,232,237,Gene/Protein	cytokine,303,311,Gene/Protein	"[{""token"": ""IFN"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""STAT family member"", ""start_span"": 59, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Stat1 - dependent immune - response genes"", ""start_span"": 91, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""intercellular adhesion molecule - 1"", ""start_span"": 141, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 179, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""IFN regulatory factor - 1"", ""start_span"": 190, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""IRF - 1"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""Stat1"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 303, ""end_span"": 311, ""type"": ""Gene/Protein""}]"	train
First, we showed that viral binding induced a number of immunoregulatory genes ( IL - 1beta, A20, NF - kappaB - p105 / p50, and IkappaBalpha) in unactivated monocytes and that neutralizing Abs to the major HCMV glycoproteins, gB ( UL55) and gH ( UL75), inhibited the induction of these genes.	IL - 1beta,81,91,Gene/Protein	A20,93,96,Gene/Protein	NF - kappaB - p105 / p50,98,122,Gene/Protein	IkappaBalpha,128,140,Gene/Protein	neutralizing Abs,176,192,Gene/Protein	HCMV glycoproteins,206,224,Gene/Protein	gB,226,228,Gene/Protein	UL55,231,235,Gene/Protein	gH,241,243,Gene/Protein	UL75,246,250,Gene/Protein	"[{""token"": ""IL - 1beta"", ""start_span"": 81, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""A20"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB - p105 / p50"", ""start_span"": 98, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""neutralizing Abs"", ""start_span"": 176, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""HCMV glycoproteins"", ""start_span"": 206, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""gB"", ""start_span"": 226, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""UL55"", ""start_span"": 231, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""gH"", ""start_span"": 241, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""UL75"", ""start_span"": 246, ""end_span"": 250, ""type"": ""Gene/Protein""}]"	train
So far, we have identified five potential targets for Oct2: the membrane glycoprotein CD36, the cysteine - rich secreted protein 3 ( CRISP - 3), a mouse homolog of the human monocyte / neutrophil elastase inhibitor ( mEI) and two unknown cDNA sequences Nov1 and Nov2.	Oct2,54,58,Gene/Protein	membrane glycoprotein,64,85,Gene/Protein	CD36,86,90,Gene/Protein	cysteine - rich secreted protein 3,96,130,Gene/Protein	CRISP - 3,133,142,Gene/Protein	human monocyte / neutrophil elastase inhibitor,168,214,Gene/Protein	mEI,217,220,Gene/Protein	cDNA sequences,238,252,Gene/Protein	Nov1,253,257,Gene/Protein	Nov2,262,266,Gene/Protein	"[{""token"": ""Oct2"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""membrane glycoprotein"", ""start_span"": 64, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CD36"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""cysteine - rich secreted protein 3"", ""start_span"": 96, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""CRISP - 3"", ""start_span"": 133, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""human monocyte / neutrophil elastase inhibitor"", ""start_span"": 168, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""mEI"", ""start_span"": 217, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""cDNA sequences"", ""start_span"": 238, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""Nov1"", ""start_span"": 253, ""end_span"": 257, ""type"": ""Gene/Protein""}, {""token"": ""Nov2"", ""start_span"": 262, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
Transfection studies of LTR reporter constructs indicated that mutation of the DSE sites abrogated the LTR - mediated synergy induced by Ctx and TNFalpha, whereas the synergy induced by Ctx and IL - 1beta was unaffected, suggesting TNFalpha and IL - 1beta cooperate differently with the cAMP / PKA activation pathway to induce HIV - 1 expression in U1 cells.	LTR reporter constructs,24,47,Gene/Protein	DSE sites,79,88,Gene/Protein	LTR,103,106,Gene/Protein	Ctx,137,140,Gene/Protein	TNFalpha,145,153,Gene/Protein	Ctx,186,189,Gene/Protein	IL - 1beta,194,204,Gene/Protein	TNFalpha,232,240,Gene/Protein	IL - 1beta,245,255,Gene/Protein	/ PKA,292,297,Gene/Protein	"[{""token"": ""LTR reporter constructs"", ""start_span"": 24, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""DSE sites"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""Ctx"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""Ctx"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""TNFalpha"", ""start_span"": 232, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1beta"", ""start_span"": 245, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""/ PKA"", ""start_span"": 292, ""end_span"": 297, ""type"": ""Gene/Protein""}]"	train
Although NAC reduced nuclear factor - kappa B ( NF - kappa B) activation in EC as measured by gel - shift assays using an oligonucleotide probe corresponding to the consensus NF - kappa B binding sites of the VCAM - 1 gene ( VCAM - NF - kappa B), the antioxidant had no appreciable effect when an oligomer corresponding to the consensus NF - kappa B binding site of the E - selectin gene ( E - selectin - NF - kappa B) was used.	nuclear factor - kappa B,21,45,Gene/Protein	NF - kappa B,48,60,Gene/Protein	oligonucleotide probe,122,143,Gene/Protein	NF - kappa B binding sites,175,201,Gene/Protein	VCAM - 1 gene,209,222,Gene/Protein	VCAM - NF - kappa B,225,244,Gene/Protein	consensus NF - kappa B binding site,327,362,Gene/Protein	E - selectin gene,370,387,Gene/Protein	E - selectin,390,402,Gene/Protein	- NF - kappa B,403,417,Gene/Protein	"[{""token"": ""nuclear factor - kappa B"", ""start_span"": 21, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 48, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""oligonucleotide probe"", ""start_span"": 122, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B binding sites"", ""start_span"": 175, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1 gene"", ""start_span"": 209, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - NF - kappa B"", ""start_span"": 225, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""consensus NF - kappa B binding site"", ""start_span"": 327, ""end_span"": 362, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin gene"", ""start_span"": 370, ""end_span"": 387, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 390, ""end_span"": 402, ""type"": ""Gene/Protein""}, {""token"": ""- NF - kappa B"", ""start_span"": 403, ""end_span"": 417, ""type"": ""Gene/Protein""}]"	train
Synergistic transactivation of the LPS response element in Drosophila Schneider cells by coexpression of c - Fos, c - Jun, c - Rel, and p65 or c - Jun and p65 required the transactivation domains of c - Jun and p65.	LPS response element,35,55,Gene/Protein	c - Fos,105,112,Gene/Protein	c - Jun,114,121,Gene/Protein	c - Rel,123,130,Gene/Protein	p65,136,139,Gene/Protein	c - Jun,143,150,Gene/Protein	p65,155,158,Gene/Protein	transactivation domains,172,195,Gene/Protein	c - Jun,199,206,Gene/Protein	p65,211,214,Gene/Protein	"[{""token"": ""LPS response element"", ""start_span"": 35, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""c - Fos"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""transactivation domains"", ""start_span"": 172, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""c - Jun"", ""start_span"": 199, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
We found, however, that PI 3 - kinase profoundly influenced the transactivation capacity of ' nuclear factor of activated T cells ' ( NF - AT) elicited by the TCR: expression of an activated form of PI 3 - kinase inhibited TCR - mediated NF - AT responses, whereas expression of a dominant negative mutant of PI 3 - kinase potently enhanced TCR - controlled NF - AT induction.	PI 3 - kinase,24,37,Gene/Protein	nuclear factor of activated T cells,94,129,Gene/Protein	NF - AT,134,141,Gene/Protein	TCR,159,162,Gene/Protein	PI 3 - kinase,199,212,Gene/Protein	TCR,223,226,Gene/Protein	NF - AT,238,245,Gene/Protein	PI 3 - kinase,309,322,Gene/Protein	TCR,341,344,Gene/Protein	NF - AT,358,365,Gene/Protein	"[{""token"": ""PI 3 - kinase"", ""start_span"": 24, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 94, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 199, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 223, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 238, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""PI 3 - kinase"", ""start_span"": 309, ""end_span"": 322, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 341, ""end_span"": 344, ""type"": ""Gene/Protein""}, {""token"": ""NF - AT"", ""start_span"": 358, ""end_span"": 365, ""type"": ""Gene/Protein""}]"	train
A dominant - negative mutant of NF - kappaB p50 that binds DNA but fails to interact with Ets proteins inhibits the synergistic activation of the HIV - 1 and HIV - 2 enhancers by NF - kappaB ( p50 + p65) and Ets - 1, suggesting that physical interaction between Ets and NF - kappaB proteins is required for the transcriptional activity of the HIV - 1 and HIV - 2 enhancers.	NF - kappaB p50,32,47,Gene/Protein	Ets proteins,90,102,Gene/Protein	HIV - 1 and HIV - 2 enhancers,146,175,Gene/Protein	NF - kappaB,179,190,Gene/Protein	p50,193,196,Gene/Protein	p65,199,202,Gene/Protein	Ets - 1,208,215,Gene/Protein	Ets,262,265,Gene/Protein	NF - kappaB proteins,270,290,Gene/Protein	HIV - 1 and HIV - 2 enhancers,343,372,Gene/Protein	"[{""token"": ""NF - kappaB p50"", ""start_span"": 32, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Ets proteins"", ""start_span"": 90, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 and HIV - 2 enhancers"", ""start_span"": 146, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB"", ""start_span"": 179, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""p50"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""Ets - 1"", ""start_span"": 208, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""Ets"", ""start_span"": 262, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappaB proteins"", ""start_span"": 270, ""end_span"": 290, ""type"": ""Gene/Protein""}, {""token"": ""HIV - 1 and HIV - 2 enhancers"", ""start_span"": 343, ""end_span"": 372, ""type"": ""Gene/Protein""}]"	train
A point mutation of a potential phosphatidylinositol 3 - kinase ( PI3 - K) binding site ( Y731EAM to Y731EAC) in 70Z / 3 disrupted the association of PI3 - K with 70Z / 3, but did not reduce the induction of NFAT activity, suggesting that the interaction between Cbl and PI3 - K is not required in the 70Z / 3 - mediated induction of NFAT.	Y731EAM,90,97,Gene/Protein	Y731EAC,101,108,Gene/Protein	70Z / 3,113,120,Gene/Protein	PI3 - K,150,157,Gene/Protein	70Z / 3,163,170,Gene/Protein	NFAT,208,212,Gene/Protein	Cbl,263,266,Gene/Protein	PI3 - K,271,278,Gene/Protein	70Z / 3,302,309,Gene/Protein	NFAT,334,338,Gene/Protein	"[{""token"": ""Y731EAM"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""Y731EAC"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""70Z / 3"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""PI3 - K"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""70Z / 3"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 208, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""Cbl"", ""start_span"": 263, ""end_span"": 266, ""type"": ""Gene/Protein""}, {""token"": ""PI3 - K"", ""start_span"": 271, ""end_span"": 278, ""type"": ""Gene/Protein""}, {""token"": ""70Z / 3"", ""start_span"": 302, ""end_span"": 309, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 334, ""end_span"": 338, ""type"": ""Gene/Protein""}]"	train
While IL - 4 does not activate STAT5, it induces expression of STAT5 - regulated genes in CTLL - 2, i. e. beta - casein, a cytokine - inducible SH2 - containing protein ( CIS), and oncostatin M ( OSM), suggesting that STAT6 activated by IL - 4 substitutes for the function of STAT5 in T cells.	IL - 4,6,12,Gene/Protein	STAT5,31,36,Gene/Protein	STAT5 - regulated genes,63,86,Gene/Protein	beta - casein,106,119,Gene/Protein	cytokine - inducible SH2 - containing protein,123,168,Gene/Protein	CIS,171,174,Gene/Protein	oncostatin M,181,193,Gene/Protein	OSM,196,199,Gene/Protein	IL - 4,237,243,Gene/Protein	STAT5,276,281,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""STAT5 - regulated genes"", ""start_span"": 63, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""beta - casein"", ""start_span"": 106, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""cytokine - inducible SH2 - containing protein"", ""start_span"": 123, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""CIS"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""oncostatin M"", ""start_span"": 181, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""OSM"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 237, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""STAT5"", ""start_span"": 276, ""end_span"": 281, ""type"": ""Gene/Protein""}]"	train
Our studies now demonstrate that HTLV - 1 Tax activates the recently identified cellular kinases IkappaB kinase alpha ( IKKalpha) and IKKbeta, which normally phosphorylate IkappaB alpha on both of its N - terminal regulatory serines in response to tumor necrosis factor alpha ( TNF - alpha) and interleukin - 1 ( IL - 1) stimulation.	Tax,42,45,Gene/Protein	cellular kinases,80,96,Gene/Protein	IkappaB kinase alpha,97,117,Gene/Protein	IKKalpha,120,128,Gene/Protein	IKKbeta,134,141,Gene/Protein	IkappaB alpha,172,185,Gene/Protein	tumor necrosis factor alpha,248,275,Gene/Protein	TNF - alpha,278,289,Gene/Protein	interleukin - 1,295,310,Gene/Protein	IL - 1,313,319,Gene/Protein	"[{""token"": ""Tax"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""cellular kinases"", ""start_span"": 80, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB kinase alpha"", ""start_span"": 97, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""IKKalpha"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""IKKbeta"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IkappaB alpha"", ""start_span"": 172, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 248, ""end_span"": 275, ""type"": ""Gene/Protein""}, {""token"": ""TNF - alpha"", ""start_span"": 278, ""end_span"": 289, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1"", ""start_span"": 295, ""end_span"": 310, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1"", ""start_span"": 313, ""end_span"": 319, ""type"": ""Gene/Protein""}]"	train
We have previously reported that the T lymphocytes of a child with severe combined immunodeficiency are defective in the transcription of several lymphokine genes that include IL2, IL3, IL4, and IL5, which encode interleukins 2, 3, 4, and 5 ( IL - 2, - 3, - 4, and - 5).	lymphokine genes,146,162,Gene/Protein	IL2,176,179,Gene/Protein	IL3,181,184,Gene/Protein	IL4,186,189,Gene/Protein	IL5,195,198,Gene/Protein	interleukins,213,225,Gene/Protein	IL - 2,243,249,Gene/Protein	- 3,251,254,Gene/Protein	- 4,256,259,Gene/Protein	- 5,265,268,Gene/Protein	"[{""token"": ""lymphokine genes"", ""start_span"": 146, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""IL2"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""IL3"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""IL4"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""IL5"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""interleukins"", ""start_span"": 213, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 243, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""- 3"", ""start_span"": 251, ""end_span"": 254, ""type"": ""Gene/Protein""}, {""token"": ""- 4"", ""start_span"": 256, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""- 5"", ""start_span"": 265, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
The Rel / NF - kappa B family of transcription factors is composed of two distinct subgroups, proteins that undergo proteolytic processing and contain SWI6 / ankyrin repeats in their carboxyl termini ( p105, p98), and those without such repeats that do not require processing ( p65, c - Rel, RelB, and Dorsal).	Rel / NF - kappa B family,4,29,Gene/Protein	transcription factors,33,54,Gene/Protein	SWI6 / ankyrin repeats,151,173,Gene/Protein	carboxyl termini,183,199,Gene/Protein	p105,202,206,Gene/Protein	p98,208,211,Gene/Protein	p65,278,281,Gene/Protein	c - Rel,283,290,Gene/Protein	RelB,292,296,Gene/Protein	Dorsal,302,308,Gene/Protein	"[{""token"": ""Rel / NF - kappa B family"", ""start_span"": 4, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 33, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""SWI6 / ankyrin repeats"", ""start_span"": 151, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""carboxyl termini"", ""start_span"": 183, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""p98"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 278, ""end_span"": 281, ""type"": ""Gene/Protein""}, {""token"": ""c - Rel"", ""start_span"": 283, ""end_span"": 290, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 292, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""Dorsal"", ""start_span"": 302, ""end_span"": 308, ""type"": ""Gene/Protein""}]"	train
In this study, we demonstrate reconstitution of a cell - free processing system and demonstrate directly that: ( a) the ubiquitin - proteasome system is involved in processing of the intact p105 precursor, ( b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, ( c) the recently discovered novel species of the ubiquitin - carrier protein, E2 - F1, that is involved in the conjugation and degradation of p53, is also required for the limited processing of the p105 precursor, and ( d) a novel, approximately 320 - kDa species of ubiquitin - protein ligase, is involved in the process.	ubiquitin,120,129,Gene/Protein	- proteasome,130,142,Gene/Protein	p105,190,194,Gene/Protein	ubiquitin,226,235,Gene/Protein	ubiquitin - carrier protein,356,383,Gene/Protein	E2 - F1,385,392,Gene/Protein	p53,449,452,Gene/Protein	p105 precursor,505,519,Gene/Protein	320 - kDa species,553,570,Gene/Protein	ubiquitin - protein ligase,574,600,Gene/Protein	"[{""token"": ""ubiquitin"", ""start_span"": 120, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""- proteasome"", ""start_span"": 130, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""p105"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitin"", ""start_span"": 226, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitin - carrier protein"", ""start_span"": 356, ""end_span"": 383, ""type"": ""Gene/Protein""}, {""token"": ""E2 - F1"", ""start_span"": 385, ""end_span"": 392, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 449, ""end_span"": 452, ""type"": ""Gene/Protein""}, {""token"": ""p105 precursor"", ""start_span"": 505, ""end_span"": 519, ""type"": ""Gene/Protein""}, {""token"": ""320 - kDa species"", ""start_span"": 553, ""end_span"": 570, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitin - protein ligase"", ""start_span"": 574, ""end_span"": 600, ""type"": ""Gene/Protein""}]"	train
In THP - 1 cells, Fc gamma R cross - linking induced NF - kappa B, which is known to bind to the regulatory region of the long terminal repeat ( LTR) of HIV - 1 and to activate HIV - 1 transcription. Anti - TNF - alpha antibody but not anti - IL - 1 beta antibody strongly inhibited both the induction of HIV - 1 - LTR - driven transcription and the induction of NF - kappa B by Fc gamma R cross - linking.	Fc gamma R,18,28,Gene/Protein	NF - kappa B,53,65,Gene/Protein	regulatory region,97,114,Gene/Protein	long terminal repeat,122,142,Gene/Protein	LTR,145,148,Gene/Protein	Anti - TNF - alpha antibody,200,227,Gene/Protein	anti - IL - 1 beta antibody,236,263,Gene/Protein	LTR,315,318,Gene/Protein	NF - kappa B,363,375,Gene/Protein	Fc gamma R,379,389,Gene/Protein	"[{""token"": ""Fc gamma R"", ""start_span"": 18, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""regulatory region"", ""start_span"": 97, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""long terminal repeat"", ""start_span"": 122, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""Anti - TNF - alpha antibody"", ""start_span"": 200, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""anti - IL - 1 beta antibody"", ""start_span"": 236, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""LTR"", ""start_span"": 315, ""end_span"": 318, ""type"": ""Gene/Protein""}, {""token"": ""NF - kappa B"", ""start_span"": 363, ""end_span"": 375, ""type"": ""Gene/Protein""}, {""token"": ""Fc gamma R"", ""start_span"": 379, ""end_span"": 389, ""type"": ""Gene/Protein""}]"	train
Using fluorescence in situ hybridization ( FISH), we show here that the genes encoding the TATA - box binding protein ( TBP), TFIIB, TFIIE alpha, TFIIE beta, RAP30, RAP74 and the 62 kDa subunit, of TFIIH are located at the human chromosomal bands 6q26 - 27, 1p21 - 22, 3q21 - 24, 8p12, 13q14, 19p13. 3 and 11p14 - 15. 1, respectively.	genes,72,77,Gene/Protein	TATA - box binding protein,91,117,Gene/Protein	TBP,120,123,Gene/Protein	TFIIB,126,131,Gene/Protein	TFIIE alpha,133,144,Gene/Protein	TFIIE beta,146,156,Gene/Protein	RAP30,158,163,Gene/Protein	RAP74,165,170,Gene/Protein	62 kDa subunit,179,193,Gene/Protein	TFIIH,198,203,Gene/Protein	"[{""token"": ""genes"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TATA - box binding protein"", ""start_span"": 91, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""TBP"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""TFIIB"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""TFIIE alpha"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""TFIIE beta"", ""start_span"": 146, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""RAP30"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""RAP74"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""62 kDa subunit"", ""start_span"": 179, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""TFIIH"", ""start_span"": 198, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
To determine the contribution of the cytoplasmic domain of the IL - 7 receptor alpha chain ( IL - 7R alpha) to activation of STAT proteins, transfectants of the murine pro - B cell line BAF3 were made that express chimeric receptors consisting of the extracellular domain of human granulocyte colony - stimulating factor receptor ( G - CSF - R) and the transmembrane and intracellular domains of human IL - 7R alpha.	cytoplasmic domain,37,55,Gene/Protein	IL - 7 receptor alpha chain,63,90,Gene/Protein	IL - 7R alpha,93,106,Gene/Protein	STAT proteins,125,138,Gene/Protein	chimeric receptors,214,232,Gene/Protein	extracellular domain,251,271,Gene/Protein	human granulocyte colony - stimulating factor receptor,275,329,Gene/Protein	G - CSF - R,332,343,Gene/Protein	transmembrane and intracellular domains,353,392,Gene/Protein	human IL - 7R alpha,396,415,Gene/Protein	"[{""token"": ""cytoplasmic domain"", ""start_span"": 37, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7 receptor alpha chain"", ""start_span"": 63, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7R alpha"", ""start_span"": 93, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""STAT proteins"", ""start_span"": 125, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""chimeric receptors"", ""start_span"": 214, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""extracellular domain"", ""start_span"": 251, ""end_span"": 271, ""type"": ""Gene/Protein""}, {""token"": ""human granulocyte colony - stimulating factor receptor"", ""start_span"": 275, ""end_span"": 329, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF - R"", ""start_span"": 332, ""end_span"": 343, ""type"": ""Gene/Protein""}, {""token"": ""transmembrane and intracellular domains"", ""start_span"": 353, ""end_span"": 392, ""type"": ""Gene/Protein""}, {""token"": ""human IL - 7R alpha"", ""start_span"": 396, ""end_span"": 415, ""type"": ""Gene/Protein""}]"	train
This effect was specifically due to Tat, since Jurkat and U937 cells cotransfected either with tat cDNA in antisense orientation ( tat / AS), tat carrying a mutation in the aminoacid cys22 - gly22 ( tat 22 / S) or with the backbone vector alone ( pRPneo - SL3) did not show any significant difference in c - fos promoter activity as compared to cells transfected with FC3 plasmid alone.	Tat,36,39,Gene/Protein	tat cDNA,95,103,Gene/Protein	tat / AS,131,139,Gene/Protein	tat,142,145,Gene/Protein	aminoacid cys22 - gly22,173,196,Gene/Protein	tat 22 / S,199,209,Gene/Protein	backbone vector alone,223,244,Gene/Protein	pRPneo - SL3,247,259,Gene/Protein	c - fos promoter,304,320,Gene/Protein	FC3 plasmid,368,379,Gene/Protein	"[{""token"": ""Tat"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""tat cDNA"", ""start_span"": 95, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""tat / AS"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""tat"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""aminoacid cys22 - gly22"", ""start_span"": 173, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""tat 22 / S"", ""start_span"": 199, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""backbone vector alone"", ""start_span"": 223, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""pRPneo - SL3"", ""start_span"": 247, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""c - fos promoter"", ""start_span"": 304, ""end_span"": 320, ""type"": ""Gene/Protein""}, {""token"": ""FC3 plasmid"", ""start_span"": 368, ""end_span"": 379, ""type"": ""Gene/Protein""}]"	train
V3 - BH10 neither blocked radiolabeled IL - 2 binding to IL - 2 receptors nor affected tyrosyl phosphorylation of several cellular proteins ( p120, p98, p96, p54, and p38), which is immediately induced by IL - 2 stimulation.	V3 - BH10,0,9,Gene/Protein	IL - 2,39,45,Gene/Protein	IL - 2 receptors,57,73,Gene/Protein	cellular proteins,122,139,Gene/Protein	p120,142,146,Gene/Protein	p98,148,151,Gene/Protein	p96,153,156,Gene/Protein	p54,158,161,Gene/Protein	p38,167,170,Gene/Protein	IL - 2,205,211,Gene/Protein	"[{""token"": ""V3 - BH10"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptors"", ""start_span"": 57, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""cellular proteins"", ""start_span"": 122, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""p120"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""p98"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""p96"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""p54"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""p38"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
The eosinophilic characteristics of YJ cells were confirmed by histochemical staining with Fast - Green / Neutral - Red and by the expression of mRNAs for eosinophil - associated granule proteins, eosinophil cationic protein ( ECP), eosinophil - derived neurotoxin ( EDN), eosinophil peroxidase ( EPO), and major basic protein ( MBP), and for the Charcot - Leyden crystal ( CLC) protein.	mRNAs,145,150,Gene/Protein	eosinophil - associated granule proteins,155,195,Gene/Protein	eosinophil cationic protein,197,224,Gene/Protein	ECP,227,230,Gene/Protein	eosinophil - derived neurotoxin,233,264,Gene/Protein	EDN,267,270,Gene/Protein	eosinophil peroxidase,273,294,Gene/Protein	EPO,297,300,Gene/Protein	major basic protein,307,326,Gene/Protein	MBP,329,332,Gene/Protein	"[{""token"": ""mRNAs"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil - associated granule proteins"", ""start_span"": 155, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil cationic protein"", ""start_span"": 197, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""ECP"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil - derived neurotoxin"", ""start_span"": 233, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""EDN"", ""start_span"": 267, ""end_span"": 270, ""type"": ""Gene/Protein""}, {""token"": ""eosinophil peroxidase"", ""start_span"": 273, ""end_span"": 294, ""type"": ""Gene/Protein""}, {""token"": ""EPO"", ""start_span"": 297, ""end_span"": 300, ""type"": ""Gene/Protein""}, {""token"": ""major basic protein"", ""start_span"": 307, ""end_span"": 326, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 329, ""end_span"": 332, ""type"": ""Gene/Protein""}]"	train
Nonetheless, a membrane - proximal region of human IL - 2R beta ( Asn240 - Leu335) was critical for JAK3 activation, and the amount of JAK3 present in activated IL - 2 receptor complexes increased with time, suggesting that stabilization of JAK3 binding to the receptor complex relies on both IL - 2R beta and IL - 2R gamma.	membrane - proximal region,15,41,Gene/Protein	IL - 2R beta,51,63,Gene/Protein	Asn240 - Leu335,66,81,Gene/Protein	JAK3,100,104,Gene/Protein	JAK3,135,139,Gene/Protein	IL - 2 receptor complexes,161,186,Gene/Protein	JAK3,241,245,Gene/Protein	receptor complex,261,277,Gene/Protein	IL - 2R beta,293,305,Gene/Protein	IL - 2R gamma,310,323,Gene/Protein	"[{""token"": ""membrane - proximal region"", ""start_span"": 15, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 51, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Asn240 - Leu335"", ""start_span"": 66, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2 receptor complexes"", ""start_span"": 161, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""JAK3"", ""start_span"": 241, ""end_span"": 245, ""type"": ""Gene/Protein""}, {""token"": ""receptor complex"", ""start_span"": 261, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R beta"", ""start_span"": 293, ""end_span"": 305, ""type"": ""Gene/Protein""}, {""token"": ""IL - 2R gamma"", ""start_span"": 310, ""end_span"": 323, ""type"": ""Gene/Protein""}]"	train
